NASDAQ:CYCC   Cyclacel Pharmaceuticals, Inc.
The title has been rejecte twice when the 200mma has been touched
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.